Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rai

Showing results (481-490 of 543) with videos related to

Pageof 55
Sort By:
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Blood|August 5, 2022
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapyShivani Handa, Jeong-Ok Lee, Andriy Derkach, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Development of potent and selective factor Xa inhibitorsR Rai, A Kolesnikov, Y Li, et al.
Blood|March 11, 2008
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selectionEmanuela M Ghia, Sonia Jain, George F Widhopf, et al.
The New England Journal of Medicine|August 27, 2004
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemiaLaura Z Rassenti, Lang Huynh, Tracy L Toy, et al.
Blood|May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesRajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood|August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cellsTill Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
The Oncologist|March 13, 2020
The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Jennifer L McQuade, Rajat R Rai, et al.
Pageof 55

Showing results (481-490 of 543) with videos related to

Sort By:
Pageof 55
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Blood|August 5, 2022
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapyShivani Handa, Jeong-Ok Lee, Andriy Derkach, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Development of potent and selective factor Xa inhibitorsR Rai, A Kolesnikov, Y Li, et al.
Blood|March 11, 2008
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selectionEmanuela M Ghia, Sonia Jain, George F Widhopf, et al.
The New England Journal of Medicine|August 27, 2004
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemiaLaura Z Rassenti, Lang Huynh, Tracy L Toy, et al.
Blood|May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesRajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood|August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cellsTill Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
The Oncologist|March 13, 2020
The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Jennifer L McQuade, Rajat R Rai, et al.
Pageof 55